PATTON et al v. ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. et al
BEVERLY PATTON and JEFFREY S. PATTON |
PRINSTON PHARMACEUTICAL INC., AUROBINDO PHARMA INC., ZHEJIANG HUAHAI PHARMACEUTICAL CO LTD, Aurobindo Pharma USA, AUROBINDO PHARMA LTD., SOLCO HEALTHCARE U.S. LLC and HUAHAI U.S. INC. |
VALSARTAN N-NITROSODIMETHYLAMINE (NDMA) PRODUCTS LIABILITY LITIGATION |
1:2019cv17609 |
September 4, 2019 |
US District Court for the District of New Jersey |
Robert B Kugler |
Joel Schneider |
Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability |
28 U.S.C. ยง 1332 |
Plaintiff |
Docket Report
This docket was last retrieved on September 4, 2019. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 10 Clerk's Notice to Counsel. (dd, ) |
Filing 9 Certified Copy of Transfer Order and docket received, Case transferred in from District of Pennsylvania Western; Case Number 2:19-cv-00981. Original file certified copy of transfer order and docket sheet received. |
Judge Robert B. Kugler and Magistrate Judge Joel Schneider added. (dd, ) |
For all Case Management Orders #click here (dd, ) |
Filing 8 Certified Copy of Conditional Transfer Order received from the District of New Jersey. (jjg) |
Filing 7 Conditional Transfer Order received from the Judicial Panel on Multi-District Litigation. (jjg) |
Filing 6 STATUS REPORT by BEVERLY PATTON, JEFFREY S. PATTON. (Attachments: #1 Exhibit, #2 Exhibit) (Ries, Jeffrey) |
Filing 5 AT&T SCHEDULING NOTICE FOR ALL TELEPHONIC CONFERENCES. Every Telephonic Conference conducted will be via an AT&T call-in number which requires participants to dial-in and provide an access code. When a Telephonic Conference is scheduled you will be instructed to refer back to this Notice and use either Dial-In No. 1 or Dial-In No. 2, both of which are contained in this Notice. This document has a security setting of "Case Participants Only", so only those individuals will have access to view the document. (bdb) |
Filing 4 STANDING ORDER AND PROCEDURES ON CIVIL MOTION PRACTICE. Signed by Chief Judge Mark R. Hornak on 8/15/19. (bdb) |
Filing 3 NOTICE that instant civil action has been designated for placement into the United States District Court's Alternative Dispute Resolution program. Parties are directed to fully complete the required 26(f) report, which includes the stipulation of selecting an ADR process. Counsel for plaintiff (or in the case of a removal action, counsel for removing defendant) shall make service of the notice on all parties. (bdb) |
Filing 2 ORDER Regarding Referral to MDL Proceeding. On or before August 26, 2019, counsel for Plaintiff shall file a status report relative to the inclusion of this action in the MDL proceeding in the District of New Jersey at MDL No. 2875, docketed in that District at its civil docket number 19-2875 (RBK/JS), along with the status of any potential transfer of this action to that MDL proceeding. Signed by Chief Judge Mark R. Hornak on 08/12/2019. Text-only entry; no PDF document will issue. This text-only entry constitutes the Order of the Court or Notice on the matter. (Hornak, Mark) |
Filing 1 COMPLAINT against AUROBINDO PHARMA INC., AUROBINDO PHARMA LTD., AUROBINDO PHARMA USA, HUAHAI U.S., INC., PRINSTON PHARMACEUTICAL, INC., SOLCO HEALTHCARE U.S., LLC, ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. (Filing fee, including Administrative fee, $400, receipt number 0315-5241703), filed by JEFFREY S. PATTON, BEVERLY PATTON. (Attachments: #1 Civil Cover Sheet) (jjg) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the New Jersey District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.